Ibanez De Caceres et al. (2004) found methylation of RASSF1A and BRCA1 promoters in plasma or serum in 25/50 (50%) and 9/50 (18%) of ovarian cancer samples, respectively, with neither promoter methylated in any of 20 controls. This evidence concerns the gene RASSF1 and ovarian cancer.